FRESENIUS MEDICAL CARE-ADR (FMS) Stock Analyst Earnings Estimates
NYSE:FMS - New York Stock Exchange, Inc. - US3580291066 - ADR
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 17.619B -1.35% | 19.398B 10.10% | 19.454B 0.29% | 19.447B -0.03% | 20.176B 3.75% | 20.963B 3.90% | 21.88B 4.37% | 23.366B 6.79% | 24.236B 3.72% | 25.702B 6.05% | 26.615B 3.55% | 27.495B 3.31% | |
| EBITDA YoY % growth | 3.402B -15.51% | 3.125B -8.15% | 3.03B -3.03% | 3.269B 7.88% | 3.62B 10.74% | 3.865B 6.77% | 3.928B 1.63% | 4.147B 5.58% | 4.653B 12.20% | 4.863B 4.51% | 5.082B 4.50% | 5.311B 4.51% | |
| EBIT YoY % growth | 1.779B -20.63% | 1.287B -27.66% | 1.278B -0.65% | 1.775B 38.85% | 2.066B 16.39% | 2.294B 11.04% | 2.598B 13.25% | 2.88B 10.85% | 3.137B 8.92% | 3.156B 0.61% | 3.281B 3.96% | 3.404B 3.75% | |
| Operating Margin | 10.10% | 6.63% | 6.57% | 9.13% | 10.24% | 10.94% | 11.87% | 12.33% | 12.94% | 12.28% | 12.33% | 12.38% | |
| EPS YoY % growth | 1.72 -25.49% | 1.55 -10.14% | 1.28 -17.23% | 1.40 8.80% | 1.71 22.72% | 1.93 12.79% | 2.32 20.24% | 2.62 12.60% | 2.53 -3.31% | 3.15 24.43% | N/A | N/A |
All data in EUR
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.43 -2.73% | 0.31 -25.48% | 0.34 -3.83% | 0.27 -34.72% | 0.29 -32.74% |
| Revenue Q2Q % growth | 4.734B -5.09% | 4.604B -2.55% | 5.302B 11.25% | 5.46B 14.71% | 4.552B -3.84% |
| EBITDA Q2Q % growth | 844.49M -61.04% | 413.54M -43.91% | 1.438B 10.98% | 1.929B 14.05% | -78.915M -109.34% |
| EBIT Q2Q % growth | 438.44M 5.49% | 167.39M -25.55% | 860.53M 117.17% | 1.056B 147.79% | 73.598M -83.21% |
All data in EUR
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 0.41 43.86% | 0.33 | 0.08 | 25.81% |
| Q2 2024 Q2Q % growth | 0.35 17.45% | 0.34 | 0.01 | 2.71% |
| Q1 2024 Q2Q % growth | 0.41 57.69% | 0.30 | 0.11 | 37.27% |
| Q4 2023 Q2Q % growth | 0.44 2.33% | 0.47 | -0.03 | -6.11% |
| Q3 2023 Q2Q % growth | 0.29 -27.85% | 0.26 | 0.02 | 9.44% |
| Q2 2023 Q2Q % growth | 0.30 -22.60% | 0.25 | 0.04 | 16.93% |
| Q1 2023 Q2Q % growth | 0.26 -23.53% | 0.26 | 0.00 | -0.29% |
| Q4 2022 Q2Q % growth | 0.43 -4.44% | 0.40 | 0.03 | 8.43% |
| Q3 2022 Q2Q % growth | 0.40 -15.96% | 0.34 | 0.05 | 15.76% |
| Q2 2022 Q2Q % growth | 0.39 1.32% | 0.42 | -0.03 | -7.29% |
| Q1 2022 Q2Q % growth | 0.34 -20.00% | 0.35 | -0.01 | -2.50% |
| Q4 2021 Q2Q % growth | 0.45 -29.13% | 0.44 | 0.01 | 2.03% |
| Q3 2021 Q2Q % growth | 0.47 -22.31% | 0.46 | 0.01 | 2.46% |
| Q2 2021 Q2Q % growth | 0.38 -36.67% | 0.38 | 0.00 | 0.20% |
| Q1 2021 Q2Q % growth | 0.43 -10.53% | 0.40 | 0.02 | 5.83% |
| Q4 2020 Q2Q % growth | 0.64 -6.62% | 0.61 | 0.03 | 4.92% |
| Q3 2020 Q2Q % growth | 0.61 | 0.58 | 0.03 | 4.36% |
| Q2 2020 Q2Q % growth | 0.60 30.43% | 0.55 | 0.05 | 10.07% |
| Q1 2020 Q2Q % growth | 0.48 -8.65% | 0.44 | 0.04 | 8.84% |
| Q4 2019 Q2Q % growth | 0.68 | 0.66 | 0.02 | 2.79% |
| Q3 2019 Q2Q % growth | 0.61 | 0.54 | 0.06 | 11.31% |
| Q2 2019 Q2Q % growth | 0.46 | 0.48 | -0.02 | -4.96% |
| Q1 2019 Q2Q % growth | 0.52 | 0.47 | 0.05 | 11.29% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 4.76B -3.57% | 4.979B | -219M | -4.40% |
| Q2 2024 Q2Q % growth | 4.766B -1.22% | 5.014B | -248M | -4.95% |
| Q1 2024 Q2Q % growth | 4.725B 0.44% | 4.681B | 43.522M | 0.93% |
| Q4 2023 Q2Q % growth | 4.988B -0.18% | 5.002B | -14M | -0.28% |
| Q3 2023 Q2Q % growth | 4.936B -3.14% | 4.952B | -16M | -0.32% |
| Q2 2023 Q2Q % growth | 4.825B 1.44% | 4.824B | 1M | 0.02% |
| Q1 2023 Q2Q % growth | 4.704B 3.42% | 4.767B | -63M | -1.32% |
| Q4 2022 Q2Q % growth | 4.997B 7.53% | 5.054B | -57.198M | -1.13% |
| Q3 2022 Q2Q % growth | 5.096B 14.74% | 5.093B | 3.166M | 0.06% |
| Q2 2022 Q2Q % growth | 4.757B 10.10% | 4.811B | -54.32M | -1.13% |
| Q1 2022 Q2Q % growth | 4.548B 8.03% | 4.516B | 32.369M | 0.72% |
| Q4 2021 Q2Q % growth | 4.647B 5.61% | 4.654B | -6.976M | -0.15% |
| Q3 2021 Q2Q % growth | 4.441B 0.63% | 4.517B | -75.634M | -1.67% |
| Q2 2021 Q2Q % growth | 4.32B -5.20% | 4.363B | -42.83M | -0.98% |
| Q1 2021 Q2Q % growth | 4.21B -6.19% | 4.272B | -61.875M | -1.45% |
| Q4 2020 Q2Q % growth | 4.4B -3.93% | 4.495B | -94.846M | -2.11% |
| Q3 2020 Q2Q % growth | 4.414B -0.12% | 4.439B | -25.232M | -0.57% |
| Q2 2020 Q2Q % growth | 4.557B 4.89% | 4.504B | 53.345M | 1.18% |
| Q1 2020 Q2Q % growth | 4.488B 8.60% | 4.466B | 21.796M | 0.49% |
| Q4 2019 Q2Q % growth | 4.58B | 4.628B | -48.037M | -1.04% |
| Q3 2019 Q2Q % growth | 4.419B | 4.461B | -41.997M | -0.94% |
| Q2 2019 Q2Q % growth | 4.345B | 4.395B | -49.968M | -1.14% |
| Q1 2019 Q2Q % growth | 4.133B | 4.151B | -18.443M | -0.44% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 4.74% | -8.89% | 0% | -0.47% |
| Revenue | 0.13% | -17.21% | -0.28% | -0.79% |